Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Karin Bakkelund, Reidar Fossmark, Ivar S. Nordrum & Helge L. Waldum. (2009) Effect of antrectomy in hypergastrinaemic female Japanese cotton rats. Scandinavian Journal of Gastroenterology 44:1, pages 32-39.
Read now
Read now
Articles from other publishers (50)
Dulce Maria Nascimento Coelho, Dilailson Carlos Costa Júnior, Daniel Moreira Alves da Silva, Ana Carolina Benício Alves, Raquell de Castro Chaves, Manoela de Oliveira Rebouças, José Tiago Valentim, Andressa Alexandre de Oliveira, Iardja Stefane Lopes Sales, Lucas Antonio Duarte Nicolau & Francisca Cléa Florenço de Sousa. (2024) Long-term administration of omeprazole in mice: a study of behavior, inflammatory, and oxidative stress alterations with focus on central nervous system. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Crossref
Kathryn E. Gropp & Aurore Varela. 2024. Haschek and Rousseaux' s Handbook of Toxicologic Pathology. Haschek and Rousseaux' s Handbook of Toxicologic Pathology
249
360
.
Thekra B Alhejaily, Zaenah Z Alamri, Fatima S ALaryani & Suhayla H Shareef. (2023) The Potential Gastro-Protective Effect of Qaysum (Achillea fragrantissima) Against Ethanol-Induced Gastric Ulcer in Wistar Albino Rats. Cureus.
Crossref
Crossref
LaRonda Morford, Ronee Baracani, Aurore Varela, Arun Tatiparthi, Mukesh Summan, Maralee McVean & Kathleen A. Funk. (2022) Juvenile Bone Toxicity: Study Considerations, Regulations, and Techniques for Assessment. International Journal of Toxicology 42:2, pages 182-197.
Crossref
Crossref
N. Doyle, A. Bédard, R. Schafbuch, G. Boyd, M. Felx, J. R. White & A. Varela. 2022. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1
27
.
Eric Lespessailles & Hechmi Toumi. (2022) Proton Pump Inhibitors and Bone Health: An Update Narrative Review. International Journal of Molecular Sciences 23:18, pages 10733.
Crossref
Crossref
Gemma Di Pompo, Katsuyuki Kusuzaki, Marco Ponzetti, Vito Ferdinando Leone, Nicola Baldini & Sofia Avnet. (2022) Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases. Biomedicines 10:8, pages 1904.
Crossref
Crossref
Reina Yoshioka, Yuichi Mine, Masato Kaku, Hiroki Nikawa & Takeshi Murayama. (2022) Lansoprazole and zoledronate delays hard tissue healing of tooth extraction sockets in dexamethasone-treated mice. Biomedicine & Pharmacotherapy 150, pages 112991.
Crossref
Crossref
Morten Steen Hansen & Morten Frost. (2022) Alliances of the gut and bone axis. Seminars in Cell & Developmental Biology 123, pages 74-81.
Crossref
Crossref
Deepa B. Rao, Alan M. Hoberman, Paul C. Brown, Aurore Varela & Brad Bolon. (2021) Regulatory Perspectives on Juvenile Animal Toxicologic Pathology. Toxicologic Pathology 49:8, pages 1393-1404.
Crossref
Crossref
Katherine A. Staines, Katherine Myers, Kirsty Little, Stuart H. Ralston & Colin Farquharson. (2021) Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In Vitro. Calcified Tissue International 109:6, pages 696-705.
Crossref
Crossref
Kristin M. Aasarød, Mats P. Mosti, Malin T. Finstad, Astrid K. Stunes, Reidar Fossmark & Unni Syversen. (2021) Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?. Bone Reports 14, pages 101095.
Crossref
Crossref
Joe D. Pagan, Laura Petroski-Rose, Alana Mann & Ashlee Hauss. (2020) Omeprazole Reduces Calcium Digestibility in Thoroughbred Horses. Journal of Equine Veterinary Science 86, pages 102851.
Crossref
Crossref
M. Hoff, E. Skovlund, S. Skurtveit, H.E. Meyer, A. Langhammer, A.J. Søgaard, U. Syversen, S. Forsmo, B. Abrahamsen & B. Schei. (2019) Proton pump inhibitors and fracture risk. The HUNT study, Norway. Osteoporosis International 31:1, pages 109-118.
Crossref
Crossref
Reidar Fossmark, Tom C. Martinsen & Helge L. Waldum. (2019) Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility. International Journal of Molecular Sciences 20:20, pages 5203.
Crossref
Crossref
Stacey L. Fossey, D. Greg Hall, Andrew W. Suttie, Martin Guillot & Aurore Varela. 2019. Toxicologic Pathology for Non-Pathologists. Toxicologic Pathology for Non-Pathologists
571
618
.
Scott C. Wagner. (2018) Proton Pump Inhibitors and Bone Health. JBJS Reviews 6:12, pages e6-e6.
Crossref
Crossref
Olena Tsyryuk & Tetyana Beregova. (2018) Чутливість парієтальних клітин до стимуляторів шлункової секреції після тривалого введення омепразолу. Lesya Ukrainka Eastern European National University Scientific Bulletin. Series: Biological Sciences:2(302), pages 228-233.
Crossref
Crossref
Aurore Varela & Jacquelin Jolette. (2018) Bone Toolbox: Biomarkers, Imaging Tools, Biomechanics, and Histomorphometry. Toxicologic Pathology 46:5, pages 511-529.
Crossref
Crossref
Milena Saqui-Salces, Amy C. Tsao, Merritt G. GillillandIIIIII & Juanita L. Merchant. (2017) Weight gain in mice on a high caloric diet and chronically treated with omeprazole depends on sex and genetic background. American Journal of Physiology-Gastrointestinal and Liver Physiology 312:1, pages G15-G23.
Crossref
Crossref
Aurore Varela. 2017. Bone Toxicology. Bone Toxicology
203
228
.
Thevaraajan Jayaraman, Muhammad Ilham Abdul Hafidz, Nazri Mustaffa & Yeong Yeh Lee. (2016) Should I Be Concerned with the Long-Term Use of Proton Pump Inhibitor Therapy?. EMJ Gastroenterology, pages 74-81.
Crossref
Crossref
Agnieszka Matuszewska, Beata Nowak, Marta Rzeszutko, Krzysztof Zduniak, Marta Szandruk, Diana Jędrzejuk, Marcin Landwójtowicz, Marek Bolanowski, Małgorzata Pieśniewska, Joanna Kwiatkowska & Adam Szeląg. (2016) Effects of long-term administration of pantoprazole on bone mineral density in young male rats. Pharmacological Reports 68:5, pages 1060-1064.
Crossref
Crossref
Kristin M Aasarød, Masoud Ramezanzadehkoldeh, Maziar Shabestari, Mats P Mosti, Astrid K Stunes, Janne E Reseland, Vidar Beisvag, Erik Fink Eriksen, Arne K Sandvik, Reinhold G Erben, Christiane Schüler, Malcolm Boyce, Bjørn H Skallerud, Unni Syversen & Reidar Fossmark. (2016) Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice. Journal of Endocrinology 230:2, pages 251-262.
Crossref
Crossref
Stephanie S. Caston, Douglas C. Fredericks, Kevin D. Kersh & Chong Wang. (2015) Short-Term Omeprazole Use Does Not Affect Serum Calcium Concentrations and Bone Density in Horses. Journal of Equine Veterinary Science 35:9, pages 714-723.
Crossref
Crossref
Yu-Fong Syu, Hsien-Hao Huang & Chih-Yen Chen. (2015) Do Proton Pump Inhibitors Contribute to Weight Gain?. Obesity Surgery 25:6, pages 1071-1072.
Crossref
Crossref
Gabriela Rezende Yanagihara, Aline Goulart de Paiva, Maurílio Pacheco Neto, Larissa Helena Torres, Antônio Carlos Shimano, Mário Jefferson Quirino Louzada, Raquel Annoni & Álvaro César de Oliveira Penoni. (2015) Effects of long-term administration of omeprazole on bone mineral density and the mechanical properties of the bone. Revista Brasileira de Ortopedia (English Edition) 50:2, pages 232-238.
Crossref
Crossref
Gabriela Rezende Yanagihara, Aline Goulart de Paiva, Maurílio Pacheco Neto, Larissa Helena Torres, Antônio Carlos Shimano, Mário Jefferson Quirino Louzada, Raquel Annoni & Álvaro César de Oliveira Penoni. (2015) Efeitos da administração em longo prazo do omeprazol sobre a densidade mineral óssea e as propriedades mecânicas do osso. Revista Brasileira de Ortopedia 50:2, pages 232-238.
Crossref
Crossref
Susannah O'Sullivan & Andrew Grey. (2014) Adverse skeletal effects of drugs – beyond Glucocorticoids. Clinical Endocrinology 82:1, pages 12-22.
Crossref
Crossref
Patric J.D. Delhanty, Bram C.J. van der Eerden & Johannes P.T.M. van Leeuwen. (2013) Ghrelin and bone. BioFactors 40:1, pages 41-48.
Crossref
Crossref
J. Keller & T. Schinke. (2013) The role of the gastrointestinal tract in calcium homeostasis and bone remodeling. Osteoporosis International 24:11, pages 2737-2748.
Crossref
Crossref
Vishal Patel, Amit Joharapurkar, Tejal Gandhi, Kirti Patel, Nirav Dhanesha, Samadhan Kshirsagar, Vipin Dhote, Jaysukh Detroja, Rajesh Bahekar & Mukul Jain. (2013)
Omeprazole improves the anti‐obesity and antidiabetic effects of exendin‐4 in
db/db
mice (奥美拉唑改善唾液素‐4 对
db/db
小鼠的减肥与降糖作用)*
. Journal of Diabetes 5:2, pages 163-171.
Crossref
Crossref
Piotr Dobrowolski, Ewa Tomaszewska, Radoslaw P. Radzki, Marek Bienko, Jerzy Wydrych, Adam Zdybel & Stefan G. Pierzynowski. (2013) Can 2-oxoglutarate prevent changes in bone evoked by omeprazole?. Nutrition 29:3, pages 556-561.
Crossref
Crossref
Thorsten Schinke & Michael Amling. 2013. Translational Endocrinology of Bone. Translational Endocrinology of Bone
63
71
.
Yu-Xiao Yang. (2012) Chronic Proton Pump Inihibitor Therapy and Calcium Metabolism. Current Gastroenterology Reports 14:6, pages 473-479.
Crossref
Crossref
Laura E Targownik, William D Leslie, Shawn K Davison, David Goltzman, Sophie A Jamal, Nancy Kreiger, Robert G Josse, Stephanie M Kaiser, Christopher S Kovacs, Jerilynn C Prior & Wei Zhou. (2012) The Relationship Between Proton Pump Inhibitor Use and Longitudinal Change in Bone Mineral Density: A Population-Based From the Canadian Multicentre Osteoporosis Study (CaMos). American Journal of Gastroenterology 107:9, pages 1361-1369.
Crossref
Crossref
Maria Pytlik, Urszula Cegieła, Joanna Folwarczna & Barbara Nowińska. (2012) Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats. Pharmacological Reports 64:3, pages 625-634.
Crossref
Crossref
Reidar Fossmark, Astrid K. Stunes, Christiane Petzold, Helge L. Waldum, Marina Rubert, Aina‐Mari Lian, Janne E. Reseland & Unni Syversen. (2011)
Decreased bone mineral density and reduced bone quality in H
+
/K
+
ATPase beta‐subunit deficient mice
. Journal of Cellular Biochemistry 113:1, pages 141-147.
Crossref
Crossref
Tetsuhide Ito & Robert T. Jensen. (2010) Association of Long-Term Proton Pump Inhibitor Therapy with Bone Fractures and Effects on Absorption of Calcium, Vitamin B12, Iron, and Magnesium. Current Gastroenterology Reports 12:6, pages 448-457.
Crossref
Crossref
Hye-Kyung Jung. (2010) Is There Any Association of Osteoporosis With Proton Pump Inhibitor Use? (Gastroenterology 2010;138:896-904). Journal of Neurogastroenterology and Motility 16:3, pages 335-336.
Crossref
Crossref
Laura E. Targownik, Lisa M. Lix, Stella Leung & William D. Leslie. (2010) Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss. Gastroenterology 138:3, pages 896-904.
Crossref
Crossref
James M. Mullin, Melissa Gabello, Lisa J. Murray, Christopher P. Farrell, Jillan Bellows, Kevin R. Wolov, Keith R. Kearney, David Rudolph & James J. Thornton. (2009) Proton pump inhibitors: actions and reactions. Drug Discovery Today 14:13-14, pages 647-660.
Crossref
Crossref
Michael D Burkitt, Andrea Varro & D Mark Pritchard. (2009) Importance of gastrin in the pathogenesis and treatment of gastric tumors. World Journal of Gastroenterology 15:1, pages 1.
Crossref
Crossref
David L. Carlton, Lissa J. Collin-Smith, Alejandro J. Daniels, David N. Deaton, Aaron S. Goetz, Christopher P. Laudeman, Thomas R. Littleton, David L. Musso, Ronda J. Ott Morgan, Jerzy R. Szewczyk & Cunyu Zhang. (2008) Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead. Bioorganic & Medicinal Chemistry Letters 18:20, pages 5451-5455.
Crossref
Crossref
Elaine W. Yu, Terri Blackwell, Kristine E. Ensrud, Teresa A. Hillier, Nancy E. Lane, Eric Orwoll & Douglas C. Bauer. (2008) Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults. Calcified Tissue International 83:4, pages 251-259.
Crossref
Crossref
Iain A. Murray & Gary H. Perdew. (2008) Omeprazole Stimulates the Induction of Human Insulin-Like Growth Factor Binding Protein-1 through Aryl Hydrocarbon Receptor Activation. Journal of Pharmacology and Experimental Therapeutics 324:3, pages 1102-1110.
Crossref
Crossref
Tatsuhiro Masaoka, Hidekazu Suzuki & Toshifumi Hibi. (2008) Gastric Epithelial Cell Modality and Proton Pump Inhibitor. Journal of Clinical Biochemistry and Nutrition 42:3, pages 191-196.
Crossref
Crossref
Martijn van der Velde, Patric Delhanty, Bram van der Eerden, Aart Jan van der Lely & Johannes van Leeuwen. 2007. Ghrelin. Ghrelin
239
258
.
A. S. RAGHUNATH, C. O'MORAIN & R. C. MCLOUGHLIN. (2005) Review article: the long‐term use of proton‐pump inhibitors. Alimentary Pharmacology & Therapeutics 22:s1, pages 55-63.
Crossref
Crossref
Atsushi Tatsuguchi, Kazumasa Miyake, Katya Gudis, Seiji Futagami, Taku Tsukui, Ken Wada, Teruyuki Kishida, Yuh Fukuda, Yuichi Sugisaki & Choitsu Sakamoto. (2004) Effect of Helicobacter pylori Infection on Ghrelin Expression in Human Gastric Mucosa. The American Journal of Gastroenterology 99:11, pages 2121-2127.
Crossref
Crossref